Published in Health Business Week, August 20th, 2004
The business reported 2003 revenues of $17 million, operating profit of $3.2 million and assets totaling $9 million. The company is an integrated business that includes Chinese herbal medicine, nutrition products, drugs and medical devices. Their distribution channels are to agencies, wholesalers, retailers, hospitals and direct to consumers.
Purchase terms include cash and convertible preferred stock priced at $2.00 and $3.00 per share, respectively, with lock-up terms regarding sale. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.